Novo Nordisk A/S (NOVO:CA) Discusses Obesity and Diabetes Portfolio Progress and Pill Launch Milestones at R&D Event Transcript
· seekingalpha.com
Novo Nordisk A/S (NOVO:CA) Discusses Obesity and Diabetes Portfolio Progress and Pill Launch Milestones at R&D Event June 7, 2026 7:30 PM EDTCompany...
Presentation
Michael Novod
Senior VP & Head of Investor Relations
All right. Good evening, and welcome to the 2026 Novo Nordisk Investor Event in connection ...